HCPCS code Q5112 — Inj ontruzant 10 mg. Status: Active. Effective Oct 1, 2023. Source: CMS HCPCS Level II.

Q5112

Active

Inj ontruzant 10 mg

Injection, trastuzumab-dttb, biosimilar, (ontruzant), 10 mg

Category: Temporary
Section: Q-codes: Temporary Codes
Effective: Oct 1, 2023
Code type: alphanumeric
OPPS Status: K — Non-pass-through drugs and biologicals
OPPS APC: 9382

MUE — Medically Unlikely Edits

Maximum units of Q5112 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
Outpatient Hospital 120
Practitioner Services 120

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
78206-0147-01 Ontruzant
78206-0148-01 Ontruzant

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2023-Q4
    Inj ontruzant 10 mg